Is Familial Mediterranean Fever a thrombotic disease or not?

European Journal of Pediatrics

Volumn 167, Issue 3, 2008, Pages 279-285

  Demirel, Atalay ^a   Celkan, Tiraje ^a,b   Kasapcopur, Ozgur ^a   Bilgen, Hulya ^a   Ozkan, Alp ^a   Apak, Hilmi ^a   Arısoy, Nil ^a   Yıldız, Inci ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Coagulation; Familial Mediterranean Fever; PAI; t PA

Indexed keywords

BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOSIS;

EID: 39049167440     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0475-2     Document Type: Article

References (33)

1. Agirbasli M, Inanc N, Baykan OA, Direskeneli H (2006) The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders. Clin Exp Rheumatol 24:580-583
2. Aksu G, Ozturk C, Kavakli K, Genel F, Kutukculer N (2007) Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol 26:366-370
3. Amaral A, Opal SM, Vincent JL (2004) Coagulation in sepsis. Intensive Care Med 30:1032-1040
4. Baykal Y, Saglam K, YIlmaz I, TaslIpInar A, AkIncI SB, Inal A (2003) Serum sIL-2r, IL-6, IL-10 and TNF alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99-101
5. Ben-Chetrit, Levy M (1998) Familial Mediterranean fever. Lancet 351:659-664
6. Dettenmeier P, Swindell B, Stroud M, Arkins N, Howard A (2003) Role of activated protein C in the pathophysiology of severe sepsis. Am J Crit Care 12:518-524
7. Ertenli I, Kiraz S, Ozturk MA, Haznedaroglu IC, Celik I, KirazlI S, Calguneri M (2001) Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever. Rheumatol Int 20:217-220
8. Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost 1:1343-1348
9. Furui J, Ishii M, Ikeda H, Muta H, Egami K, Sugahara Y, Himeno W, Akagi T, Kato H, Matsuishi T (2002) Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions. Acta Paediatr 91:1183-1188
10. Gang N, Drenth JP, Langevitz A, Zemer D, Brezniak N, Pras M, van der Meer JW, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 26:890-897
11. Gedalia A, Adar A, Garadischer R (1992) Familial Mediterranean fever in children. J Rheumatol 19:1-9
12. Griffin JH (2001) Control of coagulation reactions. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U (eds) Williams hematology. 6th edn. McGraw-Hill, Philadelphia, pp 1435-1451
13. Kahaleh MB, Osborn I, Le Roy EC (1985) Increased factor VIII, vWF antigen and vWF activity in scleroderma and Raynaud's phenomenon. Ann Intern Med 94:482-487
14. Kastner DL (1998) FMF: the genetics of inflammation. Hosp Prac 33:131-158
15. Knecht A, Beer FC, Pras M (1985) Serum amyloid A in familial Mediterranean fever. Ann Intern Med 102:71-72
16. Korkmaz C, Ozdogan H, Kasapcopur O, YazIcI H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79-81
17. Levi M, Biemond BJ, van Zonneveld AJ, Cate JW, Pannekoek H (1992) Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 85:305-312
18. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of Familial Mediterrenean fever. Semin Arthritis Rheum 26:612-627
19. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for diagnosis of FMF. Arthritis Rheum 40:1879-1885
20. Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA (1993) Inflammatory roles of P-selectin. J Clin Invest 92:559-570
21. Mannucci P (1998) von Willebrand Factor A marker of endothelial damage? Arterioscler Thromb Vasc Biol 18:1359-1362
22. Mantzer Y, Brzezinski A (1984) C5a inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med 311:287-290
23. Marlar RA (2002) D-dimer: Establishing a laboratory assay for ruling out venous thrombosis. Med Lab Obs 34:28-32
24. ÖzyIlkan E, Şimşek H, Telatar H (1992) Tumor necrosis factor in familial Mediterranean fever. Am J Med 92:579-580
25. Plaut D, Shafer D (2002) Utilities of the D-dimer assay. Adv Admin Lab 3:1-5
26. Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H (2004) Changes of P-selectin and E-selectin in children with Kawasaki disease. Zhonghua er ke za zhi (Chinese J Pediatr) 42:688-692
27. Ritchie JL, Alexander HD, Rea IM (2000) Flow cytometry analysis of platelet P-selectin expression in whole blood - methodological considerations. Clin Lab Haematol 22:359-363
28. Roberts HR, Monroe DM, Hoffman M (2001) Moleculer biology and biochemistry of the coagulation factors and pathways of hemostasis In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U (eds) Williams hematology. 6th edn. McGraw-Hill, Philadelphia, pp 1409-1435
29. Rozenbaum M, Katz R, Rozner I, Pollack S (1992) Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediteranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 19:416-418
30. Shatler A, Lachmi M, Livneh A, Pras M, Hahn T (1991) Tumor necrosis factor in familial Mediterranean fever. Am J Med 90:434-438
31. Touitou I (2001) The spectrum of familial Familial fever mutation. Eur J Hum Genet 9:473-483
32. van Gorp EC, Suharti C, ten Cate H, Dolmans WMV, van der Meer JWM, ten Cate JW, Brandjes DPM (1999) Infectious diseases and coagulation disorders. J Infect Dis 180:176-186
33. Vaughan DE (2005) PAI-1 and atherothrombosis. J Thromb Haemost 3:1879-1883